Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?

American Journal of Surgery

Volumn 196, Issue 4, 2008, Pages 566-568

  Murphy, Colleen D ^a   Jones, Julie L ^b   Javid, Sara Hughes ^a   Michaelson, James S ^a   Nolan, Matthew E ^a   Lipsitz, Stuart R ^b   Specht, Michelle C ^a   Lesnikoski, Beth Ann ^b   Hughes, Kevin S ^a   Gadd, Michele A ^a   Smith, Barbara L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast neoplasm; Ductal carcinoma in situ; Ductal carcinoma in situ with microinvasion; Sentinel lymph node biopsy; Sentinel lymph node micrometastases

Indexed keywords

ARTICLE; CANCER PATIENT; CARCINOMA IN SITU; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE;

ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 52049092293     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.06.011     Document Type: Article

References (10)

1. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-468
2. Cox C.E., Nguyen K., Gray R.J., et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?. Am Surg 67 (2001) 513-519
3. Dominguez F.J., Golshan M., Black D.M., et al. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Ann Surg Oncol 15 (2008) 268-273
4. de Mascarel I., MacGrogan G., Mathoulin-Pelissier S., et al. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 94 (2002) 2134-2142
5. Yen T.W., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 (2005) 516-526
6. Tan J.C., McCready D.R., Easson A.M., et al. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Ann Surg Oncol 14 (2007) 638-645
7. Broekhuizen L.N., Wijsman J.H., Peterse J.L., et al. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Eur J Surg Oncol 32 (2006) 502-506
8. Moore K.H., Sweeney K.J., Wilson M.E., et al. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Ann Surg Oncol 14 (2007) 2911-2917
9. Intra M., Rotmensz N., Veronesi P., et al. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg 247 (2008) 315-319
10. El-Tamer M., Chun J., Gill M., et al. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. Ann Surg Oncol 12 (2005) 254-259